Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Orion to receive an upfront payment of USD 290 million
Agreement strengthens and complements Merck’s oncology pipeline
RAHWAY, N.J.--(BUSINESS WIRE) July 13, 2022 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 13, 2022 Category: Pharmaceuticals Source Type: clinical trials
Merck Presents Positive Results from Phase 1/2 Study Evaluating V116, the Company ’s Investigational Pneumococcal Conjugate Vaccine for Adults
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019 1
Broad Phase 3 clinical program for V116 in vaccine-naïve and vaccine-experienced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 21, 2022 Category: Pharmaceuticals Source Type: clinical trials
Merck and Ridgeback Announce New Data For Investigational Lagevrio (molnupiravir) From Phase 3 MOVe-OUT Study
Based on Prespecified Exploratory Endpoints, a Lower Proportion of Participants Treated With Lagevrio Had an Acute Care Visit Compared to Those Who Received Placebo
Based on a Post Hoc Analysis, Fewer Required Respiratory Interventions (Including... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 7, 2022 Category: Pharmaceuticals Source Type: clinical trials
Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin
Condition: In Vitro Maturation of Oocytes Interventions: Drug: rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono; Drug: rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono Sponsor: Universitair Ziekenhuis Brussel Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2022 Category: Research Source Type: clinical trials
